nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Metoclopramide—CYP17A1—polycystic ovary syndrome	0.0801	0.366	CrCbGaD
Procaine—Clomifene—CYP11A1—polycystic ovary syndrome	0.0732	0.334	CrCbGaD
Procaine—Acidosis—Metformin—polycystic ovary syndrome	0.0624	0.145	CcSEcCtD
Procaine—Clomifene—CYP19A1—polycystic ovary syndrome	0.0379	0.173	CrCbGaD
Procaine—SCN10A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0357	0.102	CbGpPWpGaD
Procaine—Neuropathy—Metformin—polycystic ovary syndrome	0.0324	0.0755	CcSEcCtD
Procaine—Clomifene—CYP1A1—polycystic ovary syndrome	0.0279	0.127	CrCbGaD
Procaine—Sweating increased—Metformin—polycystic ovary syndrome	0.0211	0.0492	CcSEcCtD
Procaine—Drowsiness—Metformin—polycystic ovary syndrome	0.0193	0.045	CcSEcCtD
Procaine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0189	0.0441	CcSEcCtD
Procaine—Bradycardia—Metformin—polycystic ovary syndrome	0.0177	0.0411	CcSEcCtD
Procaine—Chills—Metformin—polycystic ovary syndrome	0.0156	0.0363	CcSEcCtD
Procaine—Erythema—Metformin—polycystic ovary syndrome	0.0151	0.0352	CcSEcCtD
Procaine—Vision blurred—Metformin—polycystic ovary syndrome	0.0142	0.0332	CcSEcCtD
Procaine—Tremor—Metformin—polycystic ovary syndrome	0.0141	0.033	CcSEcCtD
Procaine—SCN10A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0137	0.039	CbGpPWpGaD
Procaine—Syncope—Metformin—polycystic ovary syndrome	0.0135	0.0315	CcSEcCtD
Procaine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0133	0.0309	CcSEcCtD
Procaine—Hypertension—Metformin—polycystic ovary syndrome	0.013	0.0304	CcSEcCtD
Procaine—Oedema—Metformin—polycystic ovary syndrome	0.0123	0.0287	CcSEcCtD
Procaine—Shock—Metformin—polycystic ovary syndrome	0.0121	0.0282	CcSEcCtD
Procaine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.0121	0.0281	CcSEcCtD
Procaine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0119	0.0278	CcSEcCtD
Procaine—Hypotension—Metformin—polycystic ovary syndrome	0.0115	0.0268	CcSEcCtD
Procaine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0112	0.0262	CcSEcCtD
Procaine—Somnolence—Metformin—polycystic ovary syndrome	0.011	0.0255	CcSEcCtD
Procaine—Fatigue—Metformin—polycystic ovary syndrome	0.0106	0.0248	CcSEcCtD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—polycystic ovary syndrome	0.0106	0.03	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.0104	0.0295	CbGpPWpGaD
Procaine—HTR3A—Ion channel transport—TRPV6—polycystic ovary syndrome	0.0102	0.0291	CbGpPWpGaD
Procaine—Urticaria—Metformin—polycystic ovary syndrome	0.00979	0.0228	CcSEcCtD
Procaine—SLC6A3—Parkinsons Disease Pathway—CCNE2—polycystic ovary syndrome	0.00948	0.027	CbGpPWpGaD
Procaine—HTR3A—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00926	0.0263	CbGpPWpGaD
Procaine—BCHE—Glycerophospholipid biosynthesis—LPCAT2—polycystic ovary syndrome	0.00924	0.0263	CbGpPWpGaD
Procaine—Pruritus—Metformin—polycystic ovary syndrome	0.00872	0.0203	CcSEcCtD
Procaine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00843	0.0196	CcSEcCtD
Procaine—Dizziness—Metformin—polycystic ovary syndrome	0.00815	0.019	CcSEcCtD
Procaine—BCHE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00787	0.0224	CbGpPWpGaD
Procaine—Vomiting—Metformin—polycystic ovary syndrome	0.00784	0.0183	CcSEcCtD
Procaine—Rash—Metformin—polycystic ovary syndrome	0.00777	0.0181	CcSEcCtD
Procaine—Dermatitis—Metformin—polycystic ovary syndrome	0.00776	0.0181	CcSEcCtD
Procaine—Nausea—Metformin—polycystic ovary syndrome	0.00732	0.0171	CcSEcCtD
Procaine—BCHE—Phospholipid metabolism—LPCAT2—polycystic ovary syndrome	0.00645	0.0183	CbGpPWpGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—polycystic ovary syndrome	0.00635	0.0181	CbGpPWpGaD
Procaine—SLC6A3—Dopaminergic Neurogenesis—TH—polycystic ovary syndrome	0.00619	0.0176	CbGpPWpGaD
Procaine—BCHE—Glycerophospholipid biosynthesis—PNPLA2—polycystic ovary syndrome	0.00612	0.0174	CbGpPWpGaD
Procaine—SLC6A3—Alpha-synuclein signaling—TH—polycystic ovary syndrome	0.00603	0.0171	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00597	0.017	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—TH—polycystic ovary syndrome	0.00588	0.0167	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00548	0.0156	CbGpPWpGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—polycystic ovary syndrome	0.00543	0.0154	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00542	0.0154	CbGpPWpGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—polycystic ovary syndrome	0.00525	0.0149	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00518	0.0147	CbGpPWpGaD
Procaine—SLC6A3—Parkinsons Disease Pathway—TH—polycystic ovary syndrome	0.00512	0.0146	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.005	0.0142	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00454	0.0129	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.00441	0.0125	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PNPLA2—polycystic ovary syndrome	0.00427	0.0121	CbGpPWpGaD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00391	0.0111	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.0037	0.0105	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00356	0.0101	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00348	0.00989	CbGpPWpGaD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00346	0.00983	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00322	0.00916	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.0031	0.0088	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00294	0.00836	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.00291	0.00828	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.00282	0.00802	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.00271	0.00771	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.0026	0.00739	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.0025	0.00712	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00238	0.00676	CbGpPWpGaD
Procaine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.00235	0.00669	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00225	0.0064	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00208	0.0059	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—DLG4—polycystic ovary syndrome	0.00205	0.00582	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—DLG4—polycystic ovary syndrome	0.00199	0.00566	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.00196	0.00558	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.00179	0.0051	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.00175	0.00498	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.0017	0.00482	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00169	0.00482	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00164	0.00467	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00164	0.00467	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00162	0.00461	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00159	0.00453	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00153	0.00435	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.00151	0.00428	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.0015	0.00426	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00149	0.00423	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00149	0.00423	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00146	0.00415	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00145	0.00412	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00145	0.00412	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00143	0.00408	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00141	0.004	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00138	0.00391	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00137	0.00389	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00134	0.00382	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—NRG1—polycystic ovary syndrome	0.00133	0.00379	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.0013	0.00371	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00125	0.00355	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00124	0.00354	CbGpPWpGaD
Procaine—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00124	0.00353	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00122	0.00347	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.0012	0.00342	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00114	0.00325	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00113	0.0032	CbGpPWpGaD
Procaine—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	0.0011	0.00312	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00109	0.00311	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—DLG4—polycystic ovary syndrome	0.00108	0.00307	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00107	0.00304	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00106	0.00301	CbGpPWpGaD
Procaine—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.00101	0.00287	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00101	0.00287	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000964	0.00274	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000959	0.00273	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000943	0.00268	CbGpPWpGaD
Procaine—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000925	0.00263	CbGpPWpGaD
Procaine—BCHE—Metabolism—SUOX—polycystic ovary syndrome	0.000925	0.00263	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000913	0.0026	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—LEP—polycystic ovary syndrome	0.000901	0.00256	CbGpPWpGaD
Procaine—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.00086	0.00244	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00084	0.00239	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000833	0.00237	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000831	0.00236	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000785	0.00223	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000784	0.00223	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—INS—polycystic ovary syndrome	0.000769	0.00219	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000745	0.00212	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000744	0.00212	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000744	0.00211	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000731	0.00208	CbGpPWpGaD
Procaine—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000731	0.00208	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000703	0.002	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000692	0.00197	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000681	0.00194	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000639	0.00182	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000617	0.00175	CbGpPWpGaD
Procaine—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000612	0.00174	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000594	0.00169	CbGpPWpGaD
Procaine—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000581	0.00165	CbGpPWpGaD
Procaine—BCHE—Metabolism—STAR—polycystic ovary syndrome	0.000554	0.00157	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.00055	0.00156	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000548	0.00156	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000543	0.00155	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000533	0.00151	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000512	0.00146	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMMR—polycystic ovary syndrome	0.000494	0.0014	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000486	0.00138	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.000471	0.00134	CbGpPWpGaD
Procaine—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000471	0.00134	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000466	0.00132	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000456	0.0013	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000441	0.00125	CbGpPWpGaD
Procaine—BCHE—Metabolism—LHB—polycystic ovary syndrome	0.000429	0.00122	CbGpPWpGaD
Procaine—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.00042	0.00119	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.000407	0.00116	CbGpPWpGaD
Procaine—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	0.000374	0.00106	CbGpPWpGaD
Procaine—BCHE—Metabolism—RRM2—polycystic ovary syndrome	0.000362	0.00103	CbGpPWpGaD
Procaine—BCHE—Metabolism—YAP1—polycystic ovary syndrome	0.000349	0.000993	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000336	0.000956	CbGpPWpGaD
Procaine—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	0.000336	0.000954	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000334	0.000949	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	0.000331	0.000942	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000331	0.000941	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000329	0.000935	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000313	0.00089	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.000308	0.000876	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000284	0.000808	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.000283	0.000804	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000273	0.000778	CbGpPWpGaD
Procaine—BCHE—Metabolism—TH—polycystic ovary syndrome	0.000267	0.000758	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.000259	0.000737	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.000244	0.000693	CbGpPWpGaD
Procaine—BCHE—Metabolism—GNAS—polycystic ovary syndrome	0.000218	0.000619	CbGpPWpGaD
Procaine—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000207	0.000589	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000197	0.000559	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000183	0.000521	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPARG—polycystic ovary syndrome	0.000149	0.000422	CbGpPWpGaD
Procaine—BCHE—Metabolism—POMC—polycystic ovary syndrome	0.000147	0.000417	CbGpPWpGaD
Procaine—BCHE—Metabolism—INS—polycystic ovary syndrome	0.000146	0.000414	CbGpPWpGaD
